New chemo cocktail targets stomach cancer in the belly
NCT ID NCT04034251
First seen May 12, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study tested a new way to give chemotherapy for stomach cancer that has spread throughout the belly (peritoneal carcinomatosis). Participants received one chemo drug through a port in the belly and through a vein, plus another chemo drug by mouth. The goal was to see if this approach could help people live longer without the cancer growing. The study was stopped early after enrolling 12 people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.